Furthermore, while glycolytic genes (HK2, GAPDH, ENO1) correlate with poor survival, the analysis cannot establish whether their upregulation drives tumour aggression or is a secondary effect of MYCN‐mediated metabolic reprogramming. This evidence concerns the gene ENO1 and neoplasm.